Animal Medical Center's chief medical officer appointed to Global Lyme Alliance board

Richard E. Goldstein, DVM, DACVIM, DECVIM-CA, chief medical officer of the Animal Medical Center in New York, has been appointed by the Global Lyme Alliance (GLA) to serve on its scientific advisory board, according to a center release. GLA is a private nonprofit organization dedicated to conquering Lyme and other tick-borne disease through research and education.

Goldstein will be the only veterinarian on the scientific board, joining researchers and clinical innovators in multidisciplinary fields in Lyme and other tick-borne diseases.

“We are delighted to welcome Dr. Goldstein to GLA's growing advisory network of distinguished scientists and look forward to his input and guidance as we seek new pathways to better diagnose, treat, prevent and ultimately cure Lyme and other tick-borne diseases,” says Scott Santarella, chief executive officer of GLA in the release.

Goldstein holds dual board certifications in small animal internal medicine from the American College of Veterinary Internal Medicine as well as the European College of Veterinary Internal Medicine, Companion Animals. He graduated from the Koret School of Veterinary Medicine in Israel before completing a residency in small animal internal medicine at the University of California, Davis. Goldstein spent two years in private practice before becoming a faculty member at Cornell University's College of Veterinary Medicine, according to the release. He is an internationally respected clinician, researcher, lecturer and author, with more than 60 published papers and textbook chapters, and has served on the editorial review boards of several veterinary journals. 

In his current role as the Animal Medical Center's chief medical officer, Goldstein is responsible for all clinical activities and leads the medical staff of nearly 100 veterinarians, as well as oversees the center's postgraduate education program.

"I am very pleased to join the prestigious GLA scientific advisory board and have the opportunity to work with world renowned researchers of human Lyme disease for the benefit of all species that suffer from this terrible disease," Goldstein says in the release.